Navigation Links
Arena Pharmaceuticals to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference
Date:7/30/2009

SAN DIEGO, July 30, 2009 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today that the company is scheduled to present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference on August 5, 2009 at 2:15 p.m. Eastern Time (11:15 a.m. Pacific Time) at the Millennium Broadway Hotel in New York City. Jack Lief, Arena's President and Chief Executive Officer, is scheduled to provide an overview of the company, including its clinical development and research programs.

A live audio webcast of the presentation will be available under the investor relations section of Arena's website at www.arenapharm.com. A replay of the presentation will be available for 30 days following the event. Please connect to Arena's website several minutes prior to the start of the webcast to ensure adequate time for any software download that may be necessary.

About Arena Pharmaceuticals

Arena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Arena's most advanced drug candidate, lorcaserin, is being investigated in a Phase 3 clinical trial program for weight management. Arena's broad pipeline of novel compounds target G protein-coupled receptors, an important class of validated drug targets, and includes compounds being evaluated independently and with partners, including Merck & Co., Inc., and Ortho-McNeil-Janssen Pharmaceuticals, Inc.

Arena Pharmaceuticals(R) and Arena(R) are registered service marks of the company. "APD" is an abbreviation for Arena Pharmaceuticals Development.

'/>"/>
SOURCE Arena Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Monday, August 3, 2009
2. AHIMA Enters Multinational Arena to Support HIM Worldwide Advancement
3. Arena Pharmaceuticals Announces Pricing of Public Offering of Common Stock
4. Arena Pharmaceuticals Announces Public Offering of Common Stock
5. Cinergy Health Commentary On President Obamas Call for Cost Control, Competition in Health Insurance Arena
6. Arena Pharmaceuticals to Present at the Piper Jaffray Fourth Annual Europe Conference
7. Arena Pharmaceuticals to Receive $100 Million from Deerfield Management
8. New arenavirus discovered as cause of hemorrhagic fever outbreak in South Africa and Zambia
9. Arena Pharmaceuticals to Present at the 34th Annual Deutsche Bank Health Care Conference
10. Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints
11. Arena Pharmaceuticals to Report Fourth Quarter and Full Year 2008 Financial Results and to Host Conference Call and Webcast on Thursday, March 12, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2013)... Dalla, TX (PRWEB) May 19, 2013 ... comprehensive analysis for US, UK, Spain, Japan, Italy, ... pertaining to the molecular diagnostics laboratory practice, as ... technological trends with significant market impact during the ... of DNA probe and biochip technologies, test formats, ...
(Date:5/19/2013)... NY (PRWEB) May 19, 2013 Americans ... According to the newest American Veterinary Medical Association (AVMA) ... of American dog owners consider their dog a member ... who had said as much five years earlier. , ... dollar value of the national income dedicated to pets ...
(Date:5/19/2013)... 19, 2013 Vegas Hotel Escapes, the ... to announce the launch it's all new vacation packages ... Grand on 5/19/2013. Consumers traveling to Las Vegas will ... available on VegasHotelEscapes.com's website. Travelers will be pleased to ... competitors price. , Vegas Hotel Escapes specializes in helping ...
(Date:5/19/2013)... May 19, 2013 Passages Malibu, the ... center, has announced this week the launch of a ... brands’ social media channels. “We are always looking ... community and to get feedback regarding sobriety, what’s working ... and co-founder of the Passages Addiction Treatment Centers ...
(Date:5/19/2013)... Florida (PRWEB) May 19, 2013 ... market access, is pleased to unveil a new and ... environment that provides a powerful array of real-time communication ... in the US and abroad. , HE-Xpo is powered ... offer attendees the look and feel of being at ...
Breaking Medicine News(10 mins):Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 2Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 3Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 4Health News:Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing 2Health News:Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing 3Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 2Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 3Health News:HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access 2Health News:HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access 3
... Universal Capital,Management, Inc. (OTC Bulletin Board: UCMT.OB), ... management and strategic growth,resources to emerging growth ... of its,holdings, iVolution Medical Systems, Inc. will ... to fruition. , ...
... Schizophrenia could be caused by faulty signalling in the ... journal Molecular Psychiatry . In the biggest study ... samples donated by people with the condition have identified ... schizophrenia patients compared to controls. , Many of these ...
... Company, Inc.,s new ,Feel Good, Light Lenses are perfect decorating pieces ... economical time. , ... (PRWEB) March 3, 2009 -- ... nation, the Flag Company, Inc. recently launched ,Feel Good, Light Lenses ...
... Bingo tickets for the Cystic Fibrosis Trust and raised over £10,000 for ... ... -- JackpotCity.com Online Bingo has ensured that both the Cystic Fibrosis Trust ... fight against this life-threatening disease. , , , , ,For over 40 ...
... Guinea The southeast Pacific nation of Papua ... diverse ecosystems on Earth, has created its first national ... tropical forest larger than Singapore. , The decision by ... local communities neighboring the newly established YUS Conservation Area, ...
... the flu vaccine and flu vaccine supplies has unveiled their annual 2009 ... , ... (Vocus) March 2, 2009 -- Nationwide Medical/Surgical , a distributor ... 2009 list of what to do if exposed to the flu virus., ...
Cached Medicine News:Health News:iVolution Medical Systems to Assist Healthcare Providers With Compliance of President Obama's Stimulus Plan 2Health News:iVolution Medical Systems to Assist Healthcare Providers With Compliance of President Obama's Stimulus Plan 3Health News:Schizophrenia linked to signaling problems in new brain study 2Health News:The Flag Company, Inc. Releases 'Feel Good' Light Lenses to Help Counter Gloomy Economic Outlook 2Health News:The Flag Company, Inc. Releases 'Feel Good' Light Lenses to Help Counter Gloomy Economic Outlook 3Health News:JackpotCity.com Online Bingo Raises Over 10,000 for Cystic Fibrosis Trust 2Health News:Papua New Guinea declares first national conservation area 2Health News:Papua New Guinea declares first national conservation area 3Health News:Papua New Guinea declares first national conservation area 4Health News:Nationwide Medical/Surgical Reveals Their Help Sheet For Those Infected with Influenza Virus 2
(Date:5/16/2013)... May 16, 2013  Today, the National Patient Advocate ... House of Representatives recently approved a bill that ... charging patients higher out-of-pocket fees for newer, more expensive ... which have more severe side-effects. However, the bill was ... which will continue to be a barrier to patients ...
(Date:5/16/2013)... May 16, 2013  Amgen (NASDAQ: AMGN ) ... Tuesday, May 21, 2013, at the Sheraton New York Times ... at 10:00 a.m. Eastern Daylight Time. Joseph P. ... and Development at Amgen, will present at the conference. Live ... Calendar on Amgen,s website, www.amgen.com , under Investors. A ...
(Date:5/16/2013)... Texas , May 16, 2013  ULURU Inc. (OTCQB: ... ended March 31, 2013 and provided a review of its ... the Company is confirming the previously communicated outlook for 2013: ... , Expanding the network of distribution partners to cover ... , Positioning Altrazeal ® to be marketed in ...
Breaking Medicine Technology:National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 2National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 3ULURU Inc. Reports First Quarter 2013 Financial Results 2ULURU Inc. Reports First Quarter 2013 Financial Results 3ULURU Inc. Reports First Quarter 2013 Financial Results 4ULURU Inc. Reports First Quarter 2013 Financial Results 5
... 2, 2011 Bionovo, Inc. (NASDAQ: BNVI ), ... safe and effective treatments for women,s health and cancer, today ... clinical trial of their lead drug candidate for postmenopausal symptoms, ... community at the 13th Annual World Congress on Menopause in ...
... 2011 / PRNewswire / -- Cadence Pharmaceuticals, ... focused on in-licensing, developing and commercializing proprietary products principally ... the company,s President and CEO Ted Schroeder will present ... at 1:30pm Eastern Time (10:30am Pacific Time) during the ...
Cached Medicine Technology:Bionovo to Present the Clinical Promise of Menerba (MF101) for Postmenopausal Vasomotor Symptoms at World Congress on Menopause 2Bionovo to Present the Clinical Promise of Menerba (MF101) for Postmenopausal Vasomotor Symptoms at World Congress on Menopause 3Bionovo to Present the Clinical Promise of Menerba (MF101) for Postmenopausal Vasomotor Symptoms at World Congress on Menopause 4
... Facilitates grasping and implanting the ... and within the capsular bag without ... mm long jaws are placed in ... handle. Smooth, flat, cross action handle ...
Fine 3.0 mm platformed angled 60 degrees 10 mm from angle to tip. Serrated handle with dull finish....
Puntenney curved forceps, curved, smooth 10 mm platforms....
Hatsis tying forceps, titanium, long thin tying platforms....
Medicine Products: